Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)
Authors
Keywords
-
Journal
SEMINARS IN THROMBOSIS AND HEMOSTASIS
Volume -, Issue -, Pages -
Publisher
Georg Thieme Verlag KG
Online
2022-12-16
DOI
10.1055/s-0042-1758791
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The suboptimal fibrinolytic response in COVID‐19 is dictated by high PAI‐1
- (2022) Claire S. Whyte et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome
- (2022) Maria Alice Freitas Queiroz et al. Frontiers in Cellular and Infection Microbiology
- Circulating Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 Are Independent Predictors of Coronavirus Disease 2019 Severity: A Prospective, Observational Study
- (2021) Brandon Michael Henry et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID‐19: A single‐center prospective longitudinal study
- (2021) Ganeem K. Juneja et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease
- (2021) Gael B. Morrow et al. Frontiers in Cardiovascular Medicine
- Pulmonary embolism in patients with Covid-19 pneumonia
- (2020) Florian Bompard et al. EUROPEAN RESPIRATORY JOURNAL
- High incidence of venous thromboembolic events in anticoagulated severe COVID‐19 patients
- (2020) Jean‐François Llitjos et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Incidence of thrombotic complications in critically ill ICU patients with COVID-19
- (2020) F.A. Klok et al. THROMBOSIS RESEARCH
- Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
- (2020) Setor K. Kunutsor et al. THROMBOSIS RESEARCH
- Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy
- (2020) Corrado Lodigiani et al. THROMBOSIS RESEARCH
- COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City
- (2020) Alain C. Borczuk et al. MODERN PATHOLOGY
- Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation
- (2019) Gael B. Morrow et al. HAEMATOLOGICA
- The Global Epidemic of the Metabolic Syndrome
- (2018) Mohammad G. Saklayen CURRENT HYPERTENSION REPORTS
- The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects
- (2018) Yu Liu et al. GENE
- Thrombin stimulates increased plasminogen activator inhibitor-1 release from liver compared to lung endothelium
- (2018) Benjamin R. Huebner et al. JOURNAL OF SURGICAL RESEARCH
- Plasminogen activator inhibitor-1: a risk factor for deep vein thrombosis after total hip arthroplasty
- (2018) Ju Tang et al. Journal of Orthopaedic Surgery and Research
- PAI-1 Exacerbates White Adipose Tissue Dysfunction and Metabolic Dysregulation in High Fat Diet-Induced Obesity
- (2018) Lin Wang et al. Frontiers in Pharmacology
- Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study
- (2017) Aniket Prabhudesai et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians
- (2017) Hao Peng et al. JOURNAL OF HYPERTENSION
- The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays
- (2017) Marlien Pieters et al. PLoS One
- Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1
- (2015) Lihu Gong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults
- (2015) Philna Eksteen et al. THROMBOSIS RESEARCH
- Altered Daytime Fluctuation Pattern of Plasminogen Activator Inhibitor 1 in Type 2 Diabetes Patients with Coronary Artery Disease: A Strong Association with Persistently Elevated Plasma Insulin, Increased Insulin Resistance, and Abdominal Obesity
- (2015) Katarina Lalić et al. International Journal of Endocrinology
- Increased thrombotic and impaired fibrinolytic response to acute exercise in patients with essential hypertension: The effect of treatment with an angiotensin II receptor blocker
- (2014) E Gavriilaki et al. JOURNAL OF HUMAN HYPERTENSION
- 2013 ESH/ESC Guidelines for the management of arterial hypertension
- (2013) EUROPEAN HEART JOURNAL
- Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury
- (2013) L. E. Gralinski et al. mBio
- Gender-Specific Association of the Plasminogen Activator Inhibitor-1 4G/5G Polymorphism With Central Arterial Blood Pressure
- (2011) H. M. Bjorck et al. AMERICAN JOURNAL OF HYPERTENSION
- Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
- (2011) Zaid Al-Hamodi et al. Cardiovascular Diabetology
- Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1
- (2011) Zhonghui Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and PAI-1 plasma levels in young patients with ischemic stroke
- (2011) Adriano de Paula Sabino et al. MOLECULAR BIOLOGY REPORTS
- Platelets Retain High Levels of Active Plasminogen Activator Inhibitor 1
- (2011) Helén Brogren et al. PLoS One
- Association of vitronectin and plasminogen activator inhibitor-1 levels with the risk of metabolic syndrome and type 2 diabetes mellitus
- (2011) Marie-Christine Alessi et al. THROMBOSIS AND HAEMOSTASIS
- Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1
- (2010) M. E. Meltzer et al. BLOOD
- Plasma Plasminogen Activator Inhibitor 1 (PAI-1) and p-Selectin Levels in Urgent Hypertension: Effect of Single Dose Captopril and Nifedipin on Fibrinolytic Activity
- (2010) Ozlem Tiryaki et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- The metabolic syndrome
- (2010) Robert H Eckel et al. LANCET
- Activation and Regulation of Systemic Inflammation in ARDS
- (2009) G. Umberto Meduri et al. CHEST
- Plasminogen Activator Inhibitor-1 (PAI-1) Gene 4G/5G Promoter Polymorphism is Seen in Higher Frequency in the Indian Patients With Deep Vein Thrombosis
- (2009) Mohammed Suhail Akhter et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Biochemical properties of plasminogen activator inhibitor-1
- (2009) Daniel Miotto Dupont Frontiers in Bioscience-Landmark
- Multimarker Approach to Evaluate Correlates of Vascular Stiffness
- (2008) Wolfgang Lieb et al. CIRCULATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started